Novartis Ag (NVS) Cash from Discontinued Operations (2013 - 2023)

Novartis Ag has reported Cash from Discontinued Operations for 7 years, with the latest figure at 74000000.0 in Q3 2023.

• Quarterly Cash from Discontinued Operations fell 83.41% year-over-year to 74000000.0 in Q3 2023, while the trailing twelve-month figure through Dec 2023 was 238000000.0 (down 69.84% YoY) and the FY2023 annual result came in at 238000000.0, down 80.12% from the prior year.
• Cash from Discontinued Operations climbed to 74000000.0 in Q3 2023 per NVS's latest filing, from 59000000.0 in the prior quarter.
• Over five years, Cash from Discontinued Operations peaked at 499000000.0 in Q2 2019 and troughed at 59000000.0 in Q2 2023.
• A 3-year average of 229142857.14 and a median of 105000000.0 in 2023 frame the typical range for Cash from Discontinued Operations.
• The sharpest annual moves came in 2019 and 2023: Cash from Discontinued Operations advanced 16.05% in 2019, then tumbled 83.41% in 2023.
• Over 3 years, Cash from Discontinued Operations stood at 499000000.0 in 2019, then tumbled by 31.26% to 343000000.0 in 2022, then slumped by 78.43% to 74000000.0 in 2023.
• According to Business Quant data, Cash from Discontinued Operations over the past three periods registered 74000000.0, 59000000.0, and 105000000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.